Patent ID: 8229564

Claim:
A method for treating asthma in a subject, said method comprising the steps of: inserting a therapy delivery device into a subclavian artery or a subclavian vein of the subject; advancing the therapy delivery device to a point substantially adjacent an intraluminal target site of the autonomic nervous system (ANS); and activating the therapy delivery device to deliver a therapy signal to the intraluminal target site of the ANS to treat the asthma; and wherein the intraluminal target site is in electrical communication with nervous tissue selected from the group consisting of a spinal nerve, pre- or post-ganglionic autonomic fibers, a sympathetic chain ganglion, a thoracic sympathetic chain ganglion, a cervical ganglion, a superior cervical ganglion, a middle cervical ganglion, a lower cervical ganglion, an inferior cervical ganglion, an intramural ganglion, an esophageal plexus, a cardiac plexus, a pulmonary plexus, an anterior pulmonary plexus, and a posterior pulmonary plexus.